Evotec SE has entered into a multi-RNA target alliance with Takeda Pharmaceutical Co. to discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.   The companies will jointly identify and develop small molecules targeting a range of RNA targets aligned with Takeda’s R&D areas. The collaboration will leverage Evotec’s RNA targeting platform to optimally identify promising RNA sequences to targe...